Radioactive Tracer Market Scope And Analysis

  • Report Code : TIPRE00030001
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 150
Buy Now

Radioactive Tracer Market Scope, Analysis, and Trends by 2030

Buy Now

Radioactive Tracer Market Report Radioactive Tracer Market Size and Share Radioactive Tracer Market Scope and Analysis

Radioactive Tracer Market Report Scope

Report Attribute Details
Market size in 2022 US$ 14.68 Billion
Market Size by 2030 US$ 54.3 Billion
Global CAGR (2022 - 2030) 17.8%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Tracer Type
  • Technetium-99m & Tc-97m
  • Iodine-131
  • Iron-59
  • Lutetium-171
  • Rubidium Chloride & Ammonia
  • Scandium-46
  • Seaborgium-269
  • Hassium-269
  • Gallium Citrate Ga 67
  • Prostate-Specific Membrane Antigen
  • FDDNP & FDOPA
  • Phosphorus-32 & Chromium-51
  • Thallium-201
  • F-18 FDG
  • F-18 FAPI
  • Ga-68 FAPI
  • F-18 PSMA
  • DOTATOC/DOTANOC/DOTATATE
By Test Type
  • PET
  • SPECT
By Application
  • Oncology
  • Pulmonary
  • Neurology
  • Cardiology
By End User
  • Hospitals & Clinics
  • Diagnostic Centers
  • Academic & Research Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Rotem Industries Ltd
  • Abx Advanced Biochemical Compounds Gmbh
  • Invicro Llc
  • Cardinal Health Inc
  • Newcastle University
  • Novartis AG
  • Curium
  • Blue Earth Diagnostics Limited
  • General Electric Co

    • Competitive Landscape and Key Companies:

    Some prominent players operating in the global radioactive tracer market are Rotem Industries Ltd, ABX advanced biochemical compounds GmbH, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, Blue Earth Diagnostics Limited, General Electric Co, and IBA Radiopharma Solutions. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, allowing them to serve a large set of customers and subsequently increase their market share.